RICHMOND, British Columbia--(BUSINESS WIRE)--KLAS Research named Allscripts (NASDAQ: MDRX) Sunrise™ as 2020 Best in KLAS - Global Acute Care EMR (Canada). Allscripts Sunrise Acute Care is a clinical ...
LAS VEGAS, Dec. 8 -- Allscripts Chief Executive Officer Glen Tullman will host a webcast today, broadcasted live from the Allscripts Executive Summit in Las Vegas, to introduce two new innovations: ...
(a) Interest expense and other, net has been adjusted from the amounts presented in the statements of operations in order to remove the amortization of the fair value of the cash conversion option ...
Allscripts Partners with Opargo to Drive Improved Patient Care through Optimized Practice Management
CHICAGO, March 14, 2019 (GLOBE NEWSWIRE) -- Today, Allscripts (NASDAQ:MDRX) announced a strategic partnership with Opargo focused on delivering integrated technology to improve health care efficiency ...
CHICAGO--(BUSINESS WIRE)-- Allscripts Healthcare Solutions (NASDAQ: MDRX) today announced a strategic technology partnership with US Orthopedic Alliance (USOA), an orthopedic management services ...
Company provided more than 135 online sessions, sharing 60 hours of content and raising funds to support efforts to end child hunger “Getting in touch and being knowledgeable about your local public ...
A new service from Allscripts seeks to support physicians’ population health efforts by helping refer patients to clinical trials and reducing the time and costs of trials, bringing treatments to the ...
Allscripts reported revenue lower than Wall Street expectations in the third quarter of $402.1 million, down almost 10% year over year in results released Thursday amid continued pandemic challenges ...
Health IT company Allscripts' data analytics business is ramping up, delivering double-digit gains in the second quarter of 2021. The company's overall revenue was flat for the quarter, with a modest ...
Chicago-based Allscripts made headlines this year amid its COVID-19 response initiatives and its sale of Epsi, the company’s budgeting and analytics business. Here are five of the most-read stories ...
Fourth quarter GAAP diluted EPS of $2.14; growth of 11% in non-GAAP diluted EPS to $0.20 Full year 2018 GAAP diluted EPS of $2.04; growth of 16% in non-GAAP diluted EPS to $0.72 Closed sale of ...
(Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO) At the special meeting of Allscripts stockholders, held earlier today, 99% of the Allscripts shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results